Overall, the current investigation demonstrates that PBMT, a non‐invasive treatment, can ameliorate WD‐induced atherosclerosis through promoting the ABCA1‐medicated cholesterol efflux to inhibit foam cells formation. This evidence concerns the gene ABCA1 and Wilson disease.